InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank64
3Y CAGR-4.7%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

3Y CAGR
-4.7%/yr
vs -37.3%/yr prior
Acceleration
+32.6pp
Accelerating
Percentile
P64
Within normal range
vs 3Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202531.28%
2024-13.48%
202313.50%
202236.11%
202155.04%
2020-48.24%
2019-29.36%
2018232.90%
2017402.07%
2016-4.59%